FDA Suspends COVID-19 Vaccine Approvals: “mRNA Is Not Safe For Public Consumption”

A regulatory reckoning: From emergency use to evidence-based medicine

For years, the FDA rubber-stamped COVID-19 vaccines under emergency use authorizations (EUAs), bypassing the rigorous testing required for full approval. Even after granting full licensure to Pfizer’s and Moderna’s shots, the agency ignored glaring red flags—skyrocketing myocarditis cases in young men, sudden cardiac events in athletes, and a surge in autoimmune disorders.

Now, the FDA admits what dissenting doctors have warned all along: Antibody levels alone don’t guarantee protection. “We simply don’t know whether a healthy 52-year-old woman with a normal BMI who has had COVID-19 three times and has received six previous doses of a COVID-19 vaccine will benefit from the seventh dose,” the FDA officials wrote.

The new policy forces drugmakers to answer that question with hard data—not PR spin. Future trials must track symptomatic infections, hospitalizations, and deaths over at least six months, with control groups receiving placebos to unmask potential side effects.

The fallout: Big Pharma’s cash cow in jeopardy

Pfizer, Moderna, and Novavax—companies that raked in billions from government-backed vaccine mandates—now face an existential threat. Their business model relied on perpetual boosters, sold to every American regardless of need. With the FDA tightening standards, their revenue streams could dry up overnight.

The agency’s stance also undermines the CDC’s aggressive push for universal vaccination. For years, CDC officials dismissed natural immunity, downplayed vaccine injuries, and smeared critics as “anti-science.” Now, even the FDA acknowledges that prior infection provides robust protection—a fact censored during the pandemic.

A turning point for medical freedom

This policy shift is a victory for medical transparency, but the battle is far from over. The FDA still allows toxic adjuvants like aluminum in vaccines and has yet to address the carcinogenic chemicals lurking in childhood immunizations. Meanwhile, states like California continue stripping parents of medical rights, denying them access to their children’s vaccine records after age 12.

As RFK Jr. takes the helm at HHS, dismantling the corruption entrenched in public health agencies, this FDA decision signals a long-overdue return to evidence-based medicine. But true reform requires more than half-measures—it demands an end to the profit-driven vaccine mandates that have harmed a generation, and a full revoke of license for disastrous COVID-19 vaccines, failed flu vaccines, among other untested medical experiments.